NASDAQ:REPH - Recro Pharma Earnings History & Estimates

$7.24 +0.06 (+0.84 %)

(As of 10/17/2018 04:00 PM ET)

Previous Close$7.18

Today's Range$6.95 - $7.25

52-Week Range$4.78 - $13.05

Volume161,589 shs

Average Volume262,315 shs

Market Capitalization$147.30 million

P/E Ratio-3.59

Dividend YieldN/A

Beta-0.82

2018 EPS Consensus Estimate: ($2.66)
2019 EPS Consensus Estimate: ($2.84)

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	1	($0.54)	($0.54)	($0.54)
Q2 2018	2	($1.47)	($0.56)	($1.02)
Q3 2018	2	($0.69)	($0.51)	($0.60)
Q4 2018	2	($0.58)	($0.42)	($0.50)
Q1 2019	2	($0.46)	($0.41)	($0.44)
Q2 2019	2	($2.46)	($0.40)	($1.43)
Q3 2019	2	($0.49)	($0.48)	($0.49)
Q4 2019	2	($0.50)	($0.47)	($0.49)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
11/8/2018 (Estimated)
8/7/2018	Q2 2018	($1.34)	($0.62)	$16.81 million	$21.74 million	View	N/A
5/9/2018	Q1 2018	($0.68)	($0.65)	$17.32 million	$19.54 million	View	N/A
2/27/2018	Q4 2017	($0.85)	($0.63)	$12.88 million	$19.04 million	View	N/A
11/9/2017	Q3 2017	($0.75)	($0.48)	$13.93 million	$17.11 million	View	N/A
8/10/2017	Q2 2017	($0.54)	($0.48)	$14.90 million	$16.93 million	View	N/A
5/11/2017	Q1 2017	($0.5750)	($0.42)	$15.58 million	$18.74 million	View	N/A
3/6/2017	Q4 2016	($0.96)	($0.81)	$13.25 million	$17.36 million	View	N/A
11/10/2016	Q3 2016	($0.71)	($0.50)	$13.50 million	$16.95 million	View	N/A
8/11/2016	Q2	($0.78)	($0.83)	$18.70 million	$17.30 million	View	N/A
5/12/2016	Q1	($0.66)	($0.71)	$13.00 million	$17.70 million	View	N/A
3/24/2016	Q4	($0.43)	$1.13	$13.00 million	$16.75 million	View	N/A
11/13/2015	Q3	($0.20)	($0.24)		$16.54 million	View	N/A
8/14/2015	Q2 2015		($0.17)		$18.66 million	View	N/A
5/13/2015	Q115	($0.52)	($0.53)			View	N/A
3/25/2015	Q414	($0.68)	($0.45)			View	N/A
11/10/2014	Q314	($0.51)	($0.61)			View	N/A
8/12/2014		($0.25)	($0.36)			View	N/A
5/12/2014		($0.36)	($0.20)			View	N/A

(Earnings results data provided by Zacks Investment Research)

This page was last updated on 10/17/2018 by MarketBeat.com Staff